Nivasorexant
Nivasorexant is a potent orexin receptor antagonist[1].
Product Specifications
CAS Number
[1435480-40-2]
Product Name Alternative
ACT-539313
UNSPSC
12352005
Target
Orexin Receptor (OX Receptor)
Type
Reference compound
Related Pathways
GPCR/G Protein; Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/nivasorexant.html
Purity
99.74
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(C1=CC=C(C)C=C1N2N=CC=N2)N3[C@H](CC4=CC=CC(N5N=CC=N5)=C4)COCC3
Molecular Formula
C23H23N7O2
Molecular Weight
429.47
References & Citations
[1]WHO Drug Information. International Nonproprietary Names for Pharmaceutical
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 2
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
138129-ML750 100 µL
MHC Class II, beta Chain (MHC Class II beta Chain, MHC Class II, MHC II) (MaxLight 750) discontinued discontinued
Ask
View Details 
GTR15124133 1 Vial
Lentiviral mouse Siglec15 shRNA (UAS) - Lentiviral mouse Siglec15 shRNA (UAS) (25)
Ask
View Details MBS1487582-01 0.02 mg (E-Coli)
Recombinant Escherichia coli O6:K15:H31 Elongation factor 4 (lepA)
Ask
View Details 
MBS1487582-02 0.02 mg (Yeast)
Recombinant Escherichia coli O6:K15:H31 Elongation factor 4 (lepA)
Ask
View Details MBS1487582-03 0.1 mg (E-Coli)
Recombinant Escherichia coli O6:K15:H31 Elongation factor 4 (lepA)
Ask
View Details